https://theprint.in/health/all-about-leqembi-new-alzheimers-drug-thats-likely-to-get-us-approval-and-its-risks/1655322/
0
0
7/5/23 at 11:57am
Organization
ThePrint
Author
Mohana Basu
50 words
0
Comments
If it gets FDA's nod this week, it will be the second in a new category of medications to treat mild to moderate cases of the neurodegenerative disease in the US.
You are the first to view
Create an account
or login to join the discussion